PRKACA Antikörper (AA 563-672)
Kurzübersicht für PRKACA Antikörper (AA 563-672) (ABIN2340986)
Target
Alle PRKACA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 563-672
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- PRKACA (Protein Kinase C alpha Type, AAG6, PKC-A, PKCA, PKC-alpha, MGC102831, MGC48865)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- Partial recombinant corresponding to aa563-672 from human PRKCA (NP_002728) with GST tag. MW of the GST tag alone is 26kD.
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- PRKACA (Protein Kinase A, alpha (PRKACA))
-
Andere Bezeichnung
- PRKACA
-
NCBI Accession
- NM_002737, NP_002728
-
Pathways
- NF-kappaB Signalweg, Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-